Close
Nordic 9Nordic 9

Alexandria Venture Investments (investor - Venture Capital)

United States
See something wrong or missing? Let us know
Offices:Los Angeles
Average round investment:94.44M USD
Average number per year:2.3
Distribution: 2025 (2)2024 (1)2021 (4)
Portfolio companies: Norway ArtbioSwitzerland Haya TherapeuticsSwitzerland Bright Peak Therapeutics See the entire list
Mostly invests in: Switzerland Switzerland (3) Health services (7)
See the entire list

Showing 3 of 7 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Alexandria Venture Investments mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Alexandria Venture Investments

Name Criteria
Switzerland Mirabaud Asset Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Germany Athos Service
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
France RGreen Invest
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Belgium Belfius Bank
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Agriculture, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Prime Movers Labs
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Canada Sixty Degree Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Omega Funds
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, Norway
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Honeywell Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Hong Kong Horizons Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Agriculture, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top